Next Article in Journal
Tankyrases and Their Binding Proteins: Origins of Their Roles in Diverse Cellular Pathways
Next Article in Special Issue
Signaling Networks Regulating Metastatic Progression in Triple-Negative Breast Cancer
Previous Article in Journal
Endothelin-1 and Vasomotor Tone Following Cardioplegic Ischemia/Reperfusion and Cardiopulmonary Bypass
Previous Article in Special Issue
Targeting Lung Cancer Cell Motility Using Microbeam Radiation Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A New Single-Chain, Genetically Encoded Biosensor for RhoB GTPase Based on FRET, Useful for Live-Cell Imaging

1
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
2
Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA
*
Author to whom correspondence should be addressed.
Cells 2026, 15(4), 347; https://doi.org/10.3390/cells15040347
Submission received: 13 January 2026 / Revised: 6 February 2026 / Accepted: 11 February 2026 / Published: 14 February 2026
(This article belongs to the Special Issue Cell Migration and Invasion)

Abstract

RhoB is an atypical Rho GTPase whose function is tightly linked to its subcellular localization and membrane trafficking, reflecting its unique post-translational modifications and association with endosomal membranes in addition to the plasma membrane. Despite its implication in membrane trafficking and cytoskeletal regulation, tools to directly monitor RhoB activity in space and time have been lacking. Here, we describe the development and validation of a single-chain, genetically encoded Förster resonance energy transfer (FRET) biosensor that enables direct visualization of RhoB activity in living cells while preserving its native membrane-targeting determinants. The biosensor exhibits a large dynamic range and resolves spatially heterogeneous RhoB activity during leading-edge protrusion–retraction cycles in migrating mouse embryonic fibroblasts. To demonstrate the utility of this tool, we performed multiplex live-cell imaging with a previously developed near-infrared FRET biosensor for the exocytic Rho GTPase TC10. Quantitative morphodynamic and cross-correlation analyses reveal coordinated yet antagonistic spatiotemporal patterns of RhoB and TC10 activities at the leading edge and show that perturbation of TC10 regulation reorganizes their spatial coupling. Together, this work introduces a robust biosensor for RhoB and establishes a multiplex imaging framework to study the coordination of trafficking and signaling during cell migration.

1. Introduction

RhoB is a member of the Rho subfamily within the Ras superfamily of p21 small GTPases, sharing 71% and 78% amino acid sequence identity with the canonical RhoA and another minor paralog, RhoC, respectively [1]. Rho GTPases function as molecular switches that cycle between an active GTP-bound and an inactive GDP-bound state to regulate a wide range of biological processes. Although the N-terminal regions of these three Rho GTPases are relatively conserved, their C-terminal regions diverge significantly, contributing to their distinct cellular localization and functions. Notably, RhoB contains a higher number of polar residues in its C-terminal hypervariable region and a distinct C-terminal CAAX box compared with RhoA and RhoC, which together specify unique post-translational lipid modifications and subcellular targeting [2,3,4]. Whereas RhoA and RhoC are exclusively geranylgeranylated, RhoB can additionally undergo palmitoylation as well as both geranylgeranylation and farnesylation [3,5]. Consequently, active RhoB is not confined to the plasma membrane but also localizes to endosomes and multivesicular bodies [3].
Consistent with these properties, RhoB has been shown to play essential roles in multiple cellular processes, including migration [6,7,8,9], invasion [7,8,9], and proliferation [10,11], through its involvement in cytoskeletal and adhesion dynamics, as well as membrane receptor recycling and intracellular trafficking of signaling molecules and membrane components. Despite these diverse functions, RhoB remains comparatively understudied [12,13,14,15,16,17]. A deeper investigation of its activity and dynamics holds substantial promise for advancing our understanding of actin cytoskeleton regulation, cellular plasticity, and the intracellular trafficking pathways that support fundamental aspects of cell biology. Because the function of RhoB depends strongly on its subcellular compartmentalization and rapid cycling between active and inactive states, understanding its biology requires microscopy imaging tools capable of resolving its spatiotemporal activity in live cells, in the order of subcellular spatial and seconds temporal resolutions. In this context, the development of a dedicated single-chain, genetically encoded Förster resonance energy transfer (FRET) biosensor represents a powerful approach to overcome this limitation.
Genetically encoded, single-chain fluorescent protein (FP)-based FRET biosensors represent a class of powerful microscopy imaging tools to visualize and monitor Rho GTPase activity in living cells with high spatial and temporal resolution [18,19,20,21]. These biosensors consist of a FRET-donor and an acceptor fluorescent protein fused within a single polypeptide chain, together with the GTPase of interest and an effector-derived GTPase-binding domain [18,19,20,22,23]. Such single-chain biosensors have been successfully developed for several Rho GTPases, including the canonical members such as RhoA, Rac1, and Cdc42 [24,25,26], as well as other less extensively studied GTPases such as RhoC, Rac2, Rac3, and TC10 [27,28,29,30].
Here, we describe a new single-chain, genetically encoded fluorescent protein-based FRET biosensor for RhoB GTPase. We retained full-length RhoB at the C-terminus of the FRET biosensor, including its C-terminal hypervariable region containing palmitoylation and prenylation sites that are essential for its characteristic localization at the plasma membrane and throughout the endosomal network [3,5]. By preserving these molecular determinants, the biosensor faithfully reports RhoB activity within its native subcellular compartments. The FRET-donor fluorescent protein is monomeric ECFP [31], and the acceptor is a circularly permuted monomeric Citrine-YFP [32,33], a configuration widely used in single-chain FRET biosensors to maximize dynamic range and sensitivity.
As a proof of concept, we monitored RhoB activity at the leading edge of migrating mouse embryonic fibroblasts (MEFs). To extend this analysis, we performed simultaneous imaging of our RhoB biosensor together with a previously reported near-infrared (NIR) FRET biosensor for the small GTPase TC10 [29], a key regulator of exocytosis [29,34,35,36,37], enabling direct comparison of endocytic and exocytic signaling during cell migration. To mechanistically probe the coordination between these pathways, we perturbed p190RhoGAP, a GAP for TC10 with no known activity toward RhoB [29,38], and examined whether modulation of TC10-dependent exocytic trafficking influences RhoB activity at the leading edge. Using this approach, we directly visualized the spatiotemporal regulation of RhoB in migrating cells and uncovered a coordinated, spatially organized pattern of RhoB and TC10 activities. Comparative analysis revealed complementary yet opposing activation dynamics, consistent with the engagement of interconnected but antagonistic signaling modules that regulate membrane remodeling and protrusive behavior during cell motility. Together, these results demonstrate the power of our RhoB biosensor to dissect the coordinated molecular mechanisms that drive leading-edge motion and, more broadly, cell motility dynamics.

2. Results and Discussion

We developed a genetically encoded single-chain FRET-based biosensor for RhoB GTPase. Building on our previously published RhoA biosensor [26], the new sensor is composed of full-length RhoB and a RhoB-specific binding domain derived from Protein Kinase-N (PKN) RBD, positioned at the N- and C-termini, respectively (Figure 1A). The terminal placement of RhoB preserves its C-terminal region, which is essential for RhoB subcellular localization and interaction with its regulators [1,2,3,15,39]. The central region of the biosensor consists of two fluorescent proteins—monomeric ECFP and monomeric Citrine-YFP [40] which is circularly permuted at position 229 [41]—separated by a flexible linker of an optimized length [42] (Figure 1A). The codon usage of the donor mECFP was synonymously modified to prevent spurious expression issues in living cells [43].
Because the size of the biosensor precluded in vitro purification, biosensor characterization by fluorescence measurements was performed in live, suspended LinXe cells [23]. Analysis of the fluorescence emission spectra of constitutively active (G14V) and dominant negative (T19N) mutants revealed an approximately 70% difference in FRET ratio signal between the two states, demonstrating a large dynamic range of the biosensor (Figure 1B). We further screened the activity of the RhoB WT biosensor in the presence of the different RhoGDI isoforms (GDIα, GDIβ, and GDIγ), which act as cytosolic chaperones that bind Rho GTPases and regulate their membrane association and activity [44,45,46] (Figure 1C). Although the three RhoGDI reduced RhoB activity, GDIγ exerted the strongest inhibitory effect on the RhoB biosensor, consistent with previous reports identifying GDIγ as the only RhoGDI isoform documented to regulate RhoB [47,48]. In parallel, we examined a panel of RhoB mutants, including a fast-cycling mutant (F30L), two constitutively active mutants (Q63L and G14V), and an inactive mutant (T19N) (Figure 1C). No significant differences were detected between the active mutants and the WT biosensor, likely due to high expression levels of the constructs leading to saturation of the system and maximal activation of the WT biosensor [23,26]. As expected, the inactive mutant (T19N), for its part, exhibited reduced activity compared to WT and active mutants, consistent with the results shown in Figure 1B. To demonstrate that the elevated activity of the WT biosensor likely stems from overexpression and aberrant activation by upstream regulators, namely guanine exchange factors (GEFs), we co-expressed non-fluorescent dominant-negative Rho GTPase mutants to titrate endogenous cellular GEFs (Figure 1C). Indeed, co-expression of dominant-negative mutants of the three RhoGTPases decreased RhoB biosensor activity, with the most pronounced effect observed upon expression of dominant-negative RhoB, pointing to cellular endogenous GEF-mediated hyperactivation when the WT biosensor was overexpressed. The next step was to test a panel of GEFs and GTPase-activating proteins (GAPs), which promote GTP loading and stimulate GTP hydrolysis, respectively, and assess their effects on the activity of the WT RhoB biosensor (Figure 1E–I). This analysis is particularly relevant for RhoB, given the limited literature describing its upstream regulators. To facilitate the detection of GEF-dependent activation, we first reduced basal biosensor activity by co-expressing a GDI. Although GDIγ induced a measurable reduction in FRET ratio, as shown by titration experiments (Supplementary Figure S1), this effect remained relatively modest. Given the predominant endosomal localization of RhoB and its close functional relationship with Rab GTPases, we prioritized RabGDI, which induced a stronger reduction in RhoB biosensor activity than GDIγ (Figure 1D), and used it as a sensitized background to probe upstream regulatory inputs capable of restoring RhoB activation. Under these conditions, co-expression of canonical RhoGEFs failed to rescue RhoB biosensor activity and, in several cases, further reduced it (Figure 1E), consistent with RhoB being regulated independently of cytoskeleton-targeting Rho GTPases; RapGEFs similarly did not activate RhoB (Figure 1F). In contrast, screening of the DOCK family of GEFs revealed a selective effect, with DOCK4 significantly increasing RhoB biosensor activity (Figure 1G), a result that aligns with the established role of RhoB in regulating Rac1 endosomal trafficking. Strikingly, all tested RabGEFs robustly restored wild-type RhoB biosensor activity (Figure 1H), and Rab-associated GAPs, including the Rab-specific GAP TBC1D10 and p50RhoGAP, significantly reduced RhoB activity (Figure 1I), together identifying Rab-regulated endosomal pathways as dominant upstream regulators of RhoB. The reduction in RhoB activity observed upon expression of several RhoGEFs suggests indirect modes of regulation rather than direct activation of RhoB, potentially involving heterologous GTPase crosstalk whereby activation of other Rho family members, including RhoA, Rac1, or Cdc42, alters shared regulatory components, membrane availability, or trafficking pathways that indirectly constrain RhoB activation. Alternatively, overexpression of RhoGEFs may sequester limiting cofactors or regulatory machinery required for RhoB activation at endosomal membranes. Importantly, these inhibitory effects are consistent with the unique subcellular localization of RhoB, which predominantly signals from endosomal compartments rather than the plasma membrane; regulators that primarily act at the cell cortex or along cytoskeletal structures may therefore bias signaling away from RhoB-positive endosomes, resulting in reduced detectable RhoB activity. Together, these observations support a model in which RhoB regulation is shaped by compartment-specific signaling environments and inter-GTPase crosstalk, rather than by direct engagement of canonical RhoGEFs.
We next examined differences in biosensor activity between constitutively active and dominant-negative RhoB mutants using high-resolution microscopy in the rat adenocarcinoma cell line MTLn3. Although subsequent experiments were performed in mouse embryonic fibroblasts (MEFs) stably and inducibly expressing the RhoB biosensor, these cells exhibit low transfection efficiency and are therefore not suitable for transfection-based overexpression of biosensor mutants. To overcome this limitation, MTLn3 cells were transiently transfected with RhoB biosensors harboring either the constitutively active F30L mutation or the dominant-negative T19N mutation. Biosensor activity was then quantified by wide-field fluorescence microscopy using ratiometric analysis (Figure 1J). We observed an approximately twofold reduction in the FRET ratio in the T19N mutant compared with the F30L mutant of RhoB, confirming the robust dynamic range of our biosensors. This experiment also showed the expected peri-membrane and cytoplasmic localization of the RhoB biosensor, pointing to the correct membrane and cytoplasmic partitioning due to the intact C-terminal region of the GTPase.
Next, we tested if the activated RhoB within the biosensor could compete against binding to endogenous downstream targets, which would result in strong overexpression artifacts. We produced a version of the constitutively activated G14V biosensor that contained a non-specific binding domain derived from p21-activated kinase 1 (PAK1-PBD), which is targeted by Rac1 and Cdc42 [49]. PAK1-PBD was further rendered inert by the inclusion of three additional point mutations [25,50,51]. Glutathione S-transferase-fusion of PKN-RBD was used in excess to pull down the activated biosensor that contained an unmodified PKN-RBD or the inert PBD from the cell lysates. The pulldown assay confirmed that the excess exogenous binding domain can pull down the activated biosensor only when the internal binding domain was replaced with inert PAK1-PBD. This indicates that the internally accessible PKN-RBD and the RhoB within the biosensor backbone constitute the preferential interaction upon biosensor activation, minimizing overexpression artifacts (Figure 1K). Together, these data validate the RhoB biosensor as a reliable and specific tool for monitoring RhoB activation in living cells, preserving native localization and regulatory interactions while minimizing overexpression-associated artifacts. Moreover, our RhoB biosensor has been extensively characterized and exhibits robust performance. It incorporates the appropriate functional domains to ensure correct targeting to relevant membrane compartments and to preserve interactions with upstream regulators, thereby closely recapitulating the behavior of endogenous wild-type RhoB in cells. A detailed comparison of alternative biosensor designs, including their respective advantages and limitations, is provided in Sanchez et al., 2024 [18].
After characterizing the biosensor under static conditions, the next step was to investigate its activity in live cells to demonstrate the biological relevance of the RhoB biosensor. Given that RhoB localizes to both the plasma membrane and endosomal compartments, we chose to examine RhoB activity at the leading edge of migrating cells [1,13,15,17,39,52]. To this end, we generated MEFs stably incorporating the RhoB biosensor under tetracycline inducible promoter using retroviral transduction followed by FACS sorting [26]. This approach ensures relatively low expression levels of the biosensors and a gated control of the biosensor expression population as needed for the microscopy imaging experiments. We quantified the biosensor expression levels in our stable cell line, relative to their endogenous counterparts, by Western blotting. The biosensor expression levels required to achieve a sufficient signal-to-noise ratio in microscopy imaging were approximately 20% over the endogenous expression level of RhoB in these cells (Supplemental Figure S3A). The required signal-to-noise ratio from the biosensor for imaging, combined with the low endogenous expression levels of RhoB, resulted in a modestly higher expression ratio over the endogenous protein levels than what we have used previously for this class of biosensors [26,27,29]. The stable genetic integration of the biosensor and its induced expression in cells were well tolerated with no apparent cytotoxic effects noted. In biosensor-expressing cells, RhoB activity displays pronounced spatial heterogeneity, with elevated signals detected both at the cell periphery and within the cytoplasmic compartment. This distribution is consistent with the known subcellular localization of RhoB at the plasma membrane and endosomal structures (Figure 2A,B). This representation illustrates the ability of the biosensor to resolve spatial variations in RhoB activity at the whole-cell level.
To investigate the leading-edge dynamics, and specifically the balance between endocytic and exocytic compartments, we simultaneously monitored the exocytic network by stably co-expressing a previously published near-infrared TC10 biosensor from our laboratory [29], a key regulator of exocytosis [29,38,53]. Like the RhoB biosensor, the TC10 biosensor was also virally transduced under an inducible promoter, and the expression levels were gated by FACS to achieve a minimum signal-to-noise ratio from the biosensor sufficient for microscopy imaging, at approximately 35% of the endogenous TC10 protein levels. We also assessed whether the induction of the biosensors affected endogenous protein expression levels. While no effect was observed on the endogenous TC10 protein level, endogenous RhoB level was slightly elevated when biosensors were expressed (Supplemental Figure S3B), suggesting that higher than endogenous expression levels of the RhoB biosensor could pose a dominant negative effect, leading to a minor compensatory increase in the endogenous RhoB expression levels.
In contrast to RhoB activity in cells, TC10 activity exhibits a markedly different spatial pattern (Figure 2A,B). Highest TC10 activity is concentrated in a perinuclear region, likely corresponding to the Golgi apparatus and/or the endoplasmic reticulum, compartments known to be essential for the maturation of TC10-positive exocytic vesicles [53]. TC10 activity progressively decreases toward the plasma membrane as vesicles traffic away from their perinuclear sites of activation (Figure 2B). When focusing specifically on the leading edge during protrusion and retraction cycles, we observed an antagonistic pattern of RhoB and TC10 activities. RhoB activity was strongly enriched at the leading edge, whereas TC10 activity was relatively higher in more distal regions and progressively decreased toward the leading edge (Figure 2B).
To further extend this analysis, we perturbed the balance between the endocytic and exocytic processes by expressing a dominant-negative (R1283A) form of p190RhoGAP (p190DN) [54]. Previously, p190RhoGAP has been shown to target TC10 within the context of the leading-edge protrusion and cell migration in MDA-MB231 and HeLa cell lines [29,38] but has not been reported to directly regulate RhoB. As noted previously, MEFs display low transfection efficiency. Therefore, p190DN was expressed as a construct coupled to the fluorescent protein mRuby3 [55], allowing visual identification of transfected cells. Control cells were transfected with the fluorescent protein alone, and only cells expressing the fluorescent marker were analyzed (Figure 2A). Whole-cell-averaged analysis of RhoB and TC10 biosensor activity showed that p190DN expression did not significantly alter either biosensor signal (Supplementary Figure S2A,B). Thus, p190RhoGAP, which is known to regulate its target GTPases, including TC10, in a highly spatially and temporally restricted manner [29,38], does not measurably alter TC10 activity when averaged across the entire cell. The lack of effect on RhoB activity is likewise expected, as RhoB has not been reported to be regulated directly by p190RhoGAP, and is consistent with our spectrofluorometric GAP screening data obtained in suspended LinXe cells (Figure 1I). To more precisely analyze biosensor activity as a function of leading-edge dynamics, we performed line-scan analyses perpendicular to the cell edge under control conditions or upon expression of p190DN, and quantified biosensor activity during protrusion and retraction phases (Figure 2C,D). Under control conditions, RhoB biosensor activity remained relatively uniform regardless of the distance from the leading edge, whereas p190DN expression was associated with a modest increase in RhoB activity at the leading edge, suggesting a possible enrichment of biosensor activity at the plasma membrane. Notably, under both control and p190DN conditions, no significant differences in RhoB activity were observed between protrusion and retraction phases (Figure 2B). For the TC10 biosensor, control conditions revealed a slight decrease in activity at further distances away from the leading edge, consistent with the overall intracellular distribution of the biosensor activity. Interestingly, this spatial gradient was lost upon p190DN expression. Moreover, p190DN expression induced an increase in TC10 biosensor activity at the leading edge. These data are consistent with the previous findings that p190RhoGAP localized at the leading edge targets TC10 for GTP hydrolysis during cell protrusion and migration [38]. As observed for RhoB, TC10 biosensor activity was not significantly modulated by protrusion–retraction cycles (Figure 2B).
Following these high-level characterizations of leading-edge protrusions, we next applied morphodynamic mapping and cross-correlation analysis [56] to quantitatively relate leading-edge motion dynamics to the spatiotemporal activity patterns reported by the RhoB and TC10 biosensors at this site, a major hub of vesicular trafficking involving both endocytic and exocytic compartments. We restricted our study to non-migrating cells exhibiting robust protrusion–retraction fluctuations at the leading edge over the time course of a live cell experiment. Leading-edge movements were first analyzed using the temporal autocorrelation of the protrusion edge velocities, which revealed the characteristic periodic pattern of protrusion and retraction. This cyclic behavior and the characteristic periodicity (~200 s) were unaffected by p190DN compared to the control (Supplemental Figure S4). We further determined that the sample variance of the measured edge protrusion periodicity in control cells was ±11.1%, whereas the variance in RhoB biosensor expression levels among the same imaged cells was substantially higher (±40.2%). Despite this pronounced variability in biosensor expression, as reflected by the broader distribution and larger standard deviation (Supplemental Figure S4), edge protrusion dynamics and overall cell phenotype were not significantly affected. Therefore, any observations of the biosensor behaviors described below reflect relative modulations of the activities of the GTPases under study rather than alterations in leading-edge protrusive behavior.
To further refine the analysis of biosensor dynamics, we examined the cross-correlation between the biosensor activities and leading-edge dynamics. Biosensor activity was quantified at increasing distances from the leading-edge using measurement windows of 6 pixels wide and 3 pixels deep, positioned from 0 to 30 pixels away from the edge, corresponding to 10 successive window strips (Figure 3A) under control conditions or upon p190DN expression. For the RhoB biosensor, cross-correlation time-lag analysis revealed, under control conditions, a positive correlation between RhoB activity and protrusion, with RhoB activity lagging behind protrusion dynamics by 80 ± 44 s at the leading edge (Figure 3B, black arrow). This positive correlation was maximal at the leading edge, progressively decreased up to approximately 12–15 pixels from the edge, and then increased again to reach a stable plateau in more distal windows (Figure 3C). These observations indicate that the positive coupling between RhoB activity and protrusion dynamics is spatially restricted and not maintained uniformly with increasing distance from the leading edge. Upon expression of p190DN, no statistically significant differences were detected; however, a change in trend was apparent, characterized by a marked reduction in RhoB cross-correlation at the leading edge and a concomitant increase in more distal regions.
In contrast, when focusing on positive time lags relative to edge protrusion, RhoB exhibited a distinct behavior (Figure 3B, green arrow–C). Under control conditions, we observed the progressive emergence of a negative correlation between protrusion and RhoB activity with increasing distance from the leading edge. This relationship was associated with a temporal delay of protrusion dynamics relative to RhoB activity, leading protrusion initiation by 68 ± 51 s at 12–15 pixels from the edge, indicating that RhoB activity precedes protrusive events and is negatively correlated with protrusion in these more distal regions (Figure 3D). Upon expression of p190DN, this negative cross-correlation was abrogated (Figure 3D). These results indicate that p190RhoGAP is required for the spatial and temporal compartmentalization of RHOB activity. Although p190RhoGAP has not been previously reported to directly regulate RhoB, our data suggests that p190RhoGAP influences the coupling of the edge movement to the sequential, spatiotemporal regulation of RhoB activity. Notably, the temporal offset between the positive and negative correlations was shorter than the duration of a protrusion event, indicating that these opposing relationships occur within the same protrusion–retraction cycle. Together, these data support a sequential pattern in which RhoB activity transitions from a positive to a negative correlation with protrusion dynamics during a single protrusion cycle. Thus, p190RhoGAP-dependent spatiotemporal modulation of RhoB activity appears to be important during the dynamics of leading-edge protrusion and retraction. This may be explained by the fact that RhoB operates at the intersection of endosomal trafficking and intracellular signaling. Through its ability to regulate the trafficking of other small GTPases, RhoB may influence their spatial activation and inactivation cycles and thereby modulate cytoskeletal regulators involved in leading-edge dynamics [57,58,59]. In parallel, by controlling growth factor receptor recycling, RhoB may contribute to the spatial and temporal coordination of protrusive responses to extracellular cues [4,60]. Together, these complementary mechanisms could underlie the role of RhoB in shaping protrusion–retraction dynamics at the leading edge. Together, these analyses indicate that RhoB activity is dynamically and spatially coupled to leading-edge protrusion in a p190RhoGAP-dependent manner, revealing a structured spatiotemporal organization of RhoB signaling during protrusion–retraction cycles.
We performed the same analysis for TC10 activity in relation to protrusion dynamics (Figure 4A,B). Under control conditions, a strong negative cross-correlation between protrusion and TC10 activity was observed at the leading edge with no detectable time lag (Figure 4A). This negative correlation progressively decreased with increasing distance from the edge and was not detected in more distal regions, indicating that the relationship between TC10 activity and protrusive dynamics is spatially restricted to the leading edge. These results show that TC10 activity is inversely related to protrusion specifically at the leading edge, consistent with previous observations that TC10 GTP hydrolysis at this site is required for efficient migration by promoting fusion of exocytic vesicles through exocyst complex docking [29,38]. This spatially confined inverse relationship further suggests that TC10 activity is preferentially elevated during leading-edge retraction. Given that TC10-driven exocytosis supplies lipids to the plasma membrane [37,61], such fluctuations in TC10 activity may contribute to protrusion dynamics through cycles of membrane expansion and stabilization. Expression of p190DN strongly attenuated the negative cross-correlation at the leading edge, while the overall pattern was otherwise preserved, suggesting that p190RhoGAP-dependent TC10 inactivation is required to properly establish the spatiotemporal relationship between TC10 activity and protrusion dynamics (Figure 4B). Together, these results demonstrate that TC10 activity is inversely and spatially coupled to protrusion dynamics at the leading edge in a p190RhoGAP-dependent manner, highlighting a localized role for TC10 regulation during protrusion–retraction cycles.
Because the distribution of the cross-correlation functions for the protrusion vs. RhoB or TC10 is complex, we next sought to examine the direct cross-correlation between RhoB and TC10 activities, made possible by our direct multiplex biosensor imaging modality (Figure 5A,B). We observed no correlation between RhoB and TC10 activities at the leading edge (0–3 pixel window), as expected from their relative behaviors at the leading edge when cross-correlated against the protrusion velocities. Interestingly, a strong negative cross-correlation emerged in regions located 3–21 pixels away from the edge, which progressively weakened and ultimately disappeared at more distal positions (Figure 5A). Thus, while the individual measurements and analysis of RhoB and TC10 activities appear spatially complex at the leading edge, the pronounced and clear negative cross-correlation observed further from the edge supports a direct, antagonistic relationship between these two RhoGTPases and, indirectly, between the cellular processes they regulate—endocytosis and exocytosis, respectively. Importantly, this direct negative cross-correlation between RhoB and TC10 activities was fully abrogated upon expression of p190DN, suggesting that p190RhoGAP plays an important role in spatiotemporal regulation, compartmentalization and coordination of RhoB and TC10 activities at the leading edge (Figure 5B). Together, these analyses reveal distinct and spatially organized patterns of RhoB and TC10 activity at the leading edge, consistent with differential regulation of these GTPases during protrusion–retraction dynamics.

3. Conclusions

In this study, we report on the development and characterization of a genetically encoded, single-chain FRET biosensor for RHOB. The biosensor exhibits robust dynamic range, appropriate sensitivity to regulatory perturbations, and reliable performance across multiple imaging conditions, establishing it as a valid tool to monitor RHOB activity in living cells. To assess the biological usefulness of this biosensor, we co-expressed the RHOB biosensor with a previously described TC10 biosensor and used the multiplex biosensor modality to directly interrogate the signal coordination between these two GTPases in living cells. Based on the well-established compartmentalization of these two GTPases, with RHOB primarily associated with endosomal compartments and TC10 linked to exocytic processes, the Morphodynamic and the cross-correlation analyses revealed antagonistic activity patterns between RHOB and TC10 within the leading edge compartment of the cell, supporting the notion that these GTPases operate in opposing yet coordinated signaling regimes. Importantly, the perturbation analysis via the upstream regulator p190RhoGAP revealed a previously unknown, coordinated mechanism in the regulation of both RhoB and TC10 activities at the leading edge protrusions. Together, this work establishes a well-characterized and reliable RhoB biosensor that is readily applicable to live-cell imaging in diverse cellular contexts. The biosensor is fully compatible with viral transduction approaches and fluorescence microscopy-based analyses, making it broadly adaptable to disease-relevant models, including cancer, to explore context-dependent RhoB signaling mechanisms beyond cell migration.

4. Methods

4.1. Cell Culture

MTLn3 cells (rat adenocarcinoma) [62] were obtained from Dr. John Condeelis, and were cultured in Minimum Essential Medium (MEM, Corning, Corning, NY, USA) supplemented with 5% fetal bovine serum (FBS), 1% glutamine, and 100 I.U. penicillin and 100 µg/mL streptomycin (Invitrogen, Carlsbad, CA, USA), as previously described [63]. MEF cell line was purchased from Clontech (Mountainview, CA, USA, MEF/3T3 tet-off: Cat# 630914) [64,65] and LinXe cells (HEK293-derivative) [66,67] were obtained from Dr. Klaus Hahn, and were cultured in Dulbecco’s modified Eagle medium (DMEM, Corning, Corning, NY, USA) supplemented with 10% FBS, 1% glutamine, and penicillin/streptomycin, as previously described [68].

4.2. Transfection

For the MEF cell line, plasmid transfections were performed in OptiMEM (Invitrogen, Carlsbad, CA, USA), using TurboFect transfection reagent (Thermo Scientific, Waltham, MA, USA). Cells were plated at 5 × 104 cells/well in a 6-well plate and incubated overnight prior to transfection. Following the manufacturer’s protocols, 4 µg of total DNA was transfected into each well of a 6-well plate. Cells were treated with the transfection mixture overnight. For the MTLn3 cell line, transfections were performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Cells were plated at 2 × 105 cells/well of a 6-well plate and allowed to adhere and grow overnight. The following day, 2 µg of DNA was added to 250 µL of OptiMEM, and 4 µL of Lipofectamine 2000 was added to a separate aliquot of 250 µL of OptiMEM and incubated at room temperature for 5 min. The Lipofectamine solution was added to the DNA mixture and incubated for 20 min at room temperature. Cells were washed once with PBS, and 500 µL of OptiMEM was added to the well. The transfection mixture was added, and the media were replaced with normal culture medium 45 min later, and allowed to grow overnight.

4.3. Biosensor Construction and Production of Stable-Inducible RhoB MEF Cells

A FRET biosensor for RhoB was constructed based on the previously published RhoA, single-chain, genetically encoded biosensor backbone system [26]. Briefly, WT and mutant human RhoB GTPase sequences were PCR-amplified using the primer pair:
5′-GCTTAATTAGTTGCAAGAATTCATGGCGGCCATCCGCAAGAAGCTGGT-3′ and 5′-GCAAATATGAATTCTTACTCGAGTCATAGCACCTTGCAGCAGTTGATGCA-3′ and restriction digested with EcoRI and XhoI. The digested fragments were ligated into the pTriEX-4 vector containing the RhoA FRET biosensor backbone at the EcoRI/XhoI sites to exchange the RhoA GTPase sequence for the RhoB GTPase fragments. The binding domain was replaced from the original Rhotekin-RBD to Protein kinase N-RBD (1–100 amino acids) [69], by PCR amplification using primer pair: 5′-GCAAATATGAATTCTTACCATGGCCAGCGACGCCGTGCAGAGTGA-3′ and 5′-GCTAATGTAACAAGTATGGATCCAAGCACCACGTGGGCGTGCAGCTCCT-3′ followed by digestion with NcoI/BamHI and ligation into the biosensor backbone. The donor fluorescent protein was replaced from the original ECFP (with intact dimerization interface containing A206) to the synonymous codon modified [43] monomeric ECFP (incorporating A206K mutation) [70] through subcloning from our second generation monomeric RhoA biosensor [71], at BamHI/HindIII sites. Circularly permutated monomeric Citrine-YFP was generated using 2-step PCR amplification, with monomeric Citrine [40] as the template and using the following primer sets: 5′-GGTATTAATTAATATGCGGCCGCTATGATCACTCTCGGCATGGACGAGC-3′, 5′-GCCACCGCTGCCACCCTTGTACAGCTCGTCCATGCCGAGAGTGATCAT-3′, 5′-GCTGTACAAGGGTGGCAGCGGTGGCATGGTGAGCAAGGGCGAGGAGCTGT-3′, and 5′-CCATATTAATATATGAATTCCTTCCCGGCGGCGGTCACGAACTCCAGCA-3′, digested and ligated into the biosensor backbone at NotI/EcoRI sites. To generate the retroviral vector containing the biosensor in the tet-inducible system, the pRetro-X-DEST vector system (Clontech, Mountainview, CA, USA) was used. The pTriEX-RhoB biosensor was digested using NcoI and XhoI to extract the RhoB biosensor as a full-length cassette, which was then ligated into the pENTR-4 vector (Invitrogen) at NcoI/XhoI sites. The pENTR-RhoB biosensor was processed using Gateway cloning technique, together with the pRetro-X-Puro-DEST vector, using LR Clonase II (Invitrogen, Carlsbad, CA, USA), following the manufacturer’s protocols. The pRetro-X-Puro-RhoB biosensor was used to produce retrovirus for infecting MEF cells to produce stable/inducible tet-OFF biosensor cell line, as previously described. The base pair sequence information for RhoB biosensor is shown in Supplementary Data S1.

4.4. Fluorometry

Biosensor response characterization was performed in LinXE cells (a HEK293-derived cell line) [66,67] by transient expression of wild-type or mutant biosensor constructs, with or without upstream regulatory proteins, as described previously [26]. LinXE cells were plated overnight on poly-L-lysine-coated 6-well plates (Sigma) at a density of 9 × 105 cells per well and transfected the following day using Polyethylenimine (Sigma-Aldrich, St. Louis, MO, USA) following the optimized procedures [72]. Biosensors were co-transfected with regulatory proteins at the following plasmid ratios: 1:4 for co-expression with GDI, DN, GAPs or GEFs. Forty-eight hours post-transfection, cells were washed with PBS, briefly trypsinized, and resuspended in cold PBS. Live-cell suspensions were transferred to a quartz cuvette, and fluorescence emission spectra from 450 to 600 nm were acquired using a spectrofluorometer (Fluorolog-3 MF2; Horiba Jobin Yvon, New Brunswick, NJ, USA). Samples were excited at 433 nm. Background spectra obtained from cells transfected with an empty vector were used to correct for light scatter and cellular autofluorescence. Corrected spectra were normalized to the peak mECFP emission intensity at 475 nm to generate ratiometric emission profiles.

4.5. Pull-Down Assay

Pull-down assays were performed using purified PKN-RBD-conjugated agarose beads, as previously described [25]. Glutathione (GSH)-agarose beads (Sigma-Aldrich, St. Louis, MO, USA) were prepared by resuspending 100 mg of beads in sterile water, incubating for 1 h at 4 °C, and washing three times with water followed by two washes in resuspension buffer (50 mM Tris, pH 8.0, 40 mM EDTA, 25% sucrose). The beads were finally resuspended in 2 mL of resuspension buffer. To generate GST–PKN-RBD, the PKN Rho-binding domain (amino acids 1–100) was amplified by PCR and subcloned into the pGEX-4T1 vector (Cytiva, Marlborough, MA, USA) using BamHI and XhoI restriction sites. The resulting construct was transformed into BL21(DE3) competent bacteria (Agilent Technologies, Santa Clara, CA, USA). Bacterial cultures were grown at 37 °C with shaking (225 rpm) to an OD600 of ~1.0, and protein expression was induced with 0.2 mM IPTG. Cultures were immediately shifted to 25 °C and incubated overnight.
Cells were harvested and resuspended in resuspension buffer supplemented with 1 mM PMSF, protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA), and 2 mM β-mercaptoethanol, followed by incubation at 4 °C for 20 min. Detergent buffer (50 mM Tris, pH 8.0, 100 mM MgCl2, 0.2% Triton X-100) was added, and lysates were incubated for an additional 10 min at 4 °C. Cells were lysed by ultrasonication (4 × 45 s cycles on ice) and clarified by centrifugation at 22,000 rcf for 45 min at 4 °C. The supernatant was incubated with prepared GSH-agarose beads for 1 h at 4 °C with rotation. Beads were washed four times with wash buffer (50 mM Tris, pH 7.6, 50 mM NaCl, 5 mM MgCl2) and resuspended in 50% glycerol/wash buffer. Aliquots (100 µL) were flash-frozen in liquid nitrogen and stored at −80 °C until use.
For pull-down experiments, LinXE cells were transfected as indicated and lysed in RBD pull-down lysis buffer (50 mM Tris, pH 7.4, 500 mM NaCl, 50 mM MgCl2, 1% NP-40). Lysates were sonicated, clarified by centrifugation (22,000 rcf, 15 min, 4 °C), and an input fraction was retained. The remaining lysates were incubated with PKN-RBD agarose beads for 1 h at 4 °C, washed four times in lysis buffer, resuspended in SDS sample buffer, and analyzed by Western blotting. RhoB biosensor or fluorescently tagged RhoB proteins were detected using anti-GFP antibody (mouse; Sigma-Aldrich, St. Louis, MO, USA, clones 7.1 and 13.1). Original blots are shown in Supplementary Figure S5.

4.6. Microscopy Imaging

MEF cells stably expressing the indicated biosensors were plated on 25 mm round #1.5 glass coverslips (Warner Instruments, Hamden, CT, USA) coated with fibronectin (Sigma-Aldrich, St. Louis, MO, USA; 10 μg /mL in PBS, 1 h at room temperature) at a density of 5 × 104 cells per well. Cells were maintained in standard growth medium supplemented with 25 μM biliverdin (BV; Sigma-Aldrich, St. Louis, MO, USA) on the day of the experiment and imaged 3 h after plating. Live-cell imaging was performed at 37 °C in a closed imaging chamber using Fluororbrite DMEM without phenol red (Invitrogen, Carlsbad, CA, USA), sparged with argon gas to reduce dissolved oxygen, and supplemented with 3% fetal bovine serum, Oxyfluor reagent (1:100; Oxyrase Inc., Mansfield, OH, USA), and 10 mM dl-lactate (Sigma-Aldrich, St. Louis, MO, USA) [73]. The imaging medium did not contain exogenous BV.
Widefield FRET imaging was carried out using a custom Olympus IX83-ZDC2 microscope (Evident Scientific, Waltham, MA, USA) optimized for ratiometric biosensor imaging [68]. Image acquisition was controlled using Visiview version 7.0.0.8 (Visitron Systems GmBH, Puchheim, Germany). Images were acquired through a 40 × 1.3 NA oil-immersion objective (Olympus UIS DIC) with 2 × 2 camera binning. Simultaneous acquisition of mECFP and mCitrine emissions was achieved using two synchronized PrimeBSI-Express sCMOS cameras (Photometrics, Tucson, AZ, USA) mounted on a 4-way beamsplitter (Cairn Research Ltd., Faversham, Kent, UK) attached to the left-side emission port of the microscope. The beamsplitter was equipped with appropriate dichroics and emission filters (Chroma Technology, Rockingham, VT, USA) [68]. Two additional PrimeBSI sCMOS cameras (Photometrics, Yucson, AZ, USA) were mounted on this beamsplitter at the terminal position to simultaneously acquire miRFP670/miRFP720 FRET channels for the NIR FRETbiosensor. Inclusion of a filterwheel (Ludl Electronic Products, Hawthorne, NY, USA) in one of the terminal cameras enabled acquisition of mRuby3 as the transfection marker.
All image channels were registered prior to ratiometric calculations using pixel-by-pixel alignment based on a priori calibration and non-linear coordinate transformation [73,74]. Image processing was performed using MetaMorph version 7.10.5.476 (Molecular Devices, San Jose, CA, USA) and MATLAB version 2011a (MathWorks, Natick, MA, USA) and included flat-field correction, background and camera noise subtraction, threshold masking, ratiometric calculations, photobleaching correction, and spatial registration, as previously described [74]. The biosensors used in this study exhibited photobleaching properties comparable to those of other single-chain biosensors constructed with the same class of fluorescent proteins.

4.7. Morphodynamic Mapping and Cross-Correlation Analysis

Morphodynamic mapping and cross-correlation analyses were performed as described previously [56]. Briefly, cell edge motion was tracked from a time-lapsed image series, and measurement window segments (3 × 6 pixels) were constructed along the leading edge to quantify biosensor activities and edge velocity during complete protrusion–retraction cycles. This window size was previously determined to be diffusion-limited under the imaging conditions used, allowing each segment to be treated as an independent sampling entity. Measurement windows were progressively displaced from the leading edge in 3 pixel increments to assess the spatial coupling of biosensor activities. Temporal relationships between biosensor readouts were quantified using cross-correlation analysis (xcov, MATLAB version 2011a, MathWorks, Natick, MA, USA), with Pearson’s correlation coefficient used to assess the coupling strength. Statistical confidence intervals (95%) were determined by bootstrapping (2000 iterations) of spline-smoothed correlation functions. A total of 535 window segments from 12 cells were analyzed for control condition measurements, and 639 segments from 11 cells for p190DN condition measurements.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/cells15040347/s1: Supplementary Figure S1: RhoGDIgamma titration; Supplementary Figure S2: Activities of RhoB and TC10 biosensors at the cellular level (control and p190DN conditions) in MEFs constitutively expressing RHOB and TC10 biosensors; Supplementary Figure S3: Expression levels of RhoB and TC10, both endogenous proteins and biosensors, in MEFs constitutively expressing the RhoB and TC10 biosensors; Supplementary Figure S4: Temporal autocorrelation of the protrusion edge velocities; Supplementary Figure S5: RhoB Biosensor pull down; Supplementary Data S1: RhoB biosensor basepair sequence; Supplementary Video S1: Multiplexed RhoB and TC10 biosensors (control); Supplementary Video S2: Multiplexed RhoB and TC10 biosensors (p190DN).

Author Contributions

S.P. and L.H. conceived the project. S.P. and L.H. designed the experiments. S.P. performed the experiments. S.P. and L.H. analyzed the results. S.P. and L.H. wrote and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Institute of General Medical Sciences, grant number R35GM136226, the Chan Zuckerberg Initiative, and the Irma T. Hirschl Foundation.

Institutional Review Board Statement

Not applicable for studies not involving humans or animals. Document of Registration #250032 for Recombinant DNA, Albert Einstein College of Medicine, Department of Environmental Health and Safety.

Informed Consent Statement

Not applicable for studies not involving humans.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request. The biosensor expression constructs are available from the authors on request. The image processing tools and computational algorithms are available from the authors on request.

Acknowledgments

We thank members of the Segall and Cox laboratories at Albert Einstein College of Medicine for their helpful discussions.

Conflicts of Interest

The authors declare no competing interests.

References

  1. Eckenstaler, R.; Hauke, M.; Benndorf, R.A. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology. Biochem. Pharmacol. 2022, 206, 115321. [Google Scholar] [CrossRef] [PubMed]
  2. Schaefer, A.; Reinhard, N.R.; Hordijk, P.L. Toward understanding RhoGTPase specificity: Structure, function and local activation. Small GTPases 2014, 5, 6. [Google Scholar] [CrossRef] [PubMed]
  3. Adamson, P.; Paterson, H.F.; Hall, A. Intracellular localization of the P21rho proteins. J. Cell Biol. 1992, 119, 617–627. [Google Scholar] [CrossRef] [PubMed]
  4. Wherlock, M.; Gampel, A.; Futter, C.; Mellor, H. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase. J. Cell Sci. 2004, 117, 3221–3231. [Google Scholar] [CrossRef]
  5. Haga, R.B.; Ridley, A.J. Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases 2016, 7, 207–221. [Google Scholar] [CrossRef]
  6. Vega, F.M.; Colomba, A.; Reymond, N.; Thomas, M.; Ridley, A.J. RhoB regulates cell migration through altered focal adhesion dynamics. Open Biol. 2012, 2, 120076. [Google Scholar] [CrossRef]
  7. Bousquet, E.; Mazieres, J.; Privat, M.; Rizzati, V.; Casanova, A.; Ledoux, A.; Mery, E.; Couderc, B.; Favre, G.; Pradines, A. Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Cancer Res. 2009, 69, 6092–6099. [Google Scholar] [CrossRef]
  8. Alfano, D.; Ragno, P.; Stoppelli, M.P.; Ridley, A.J. RhoB regulates uPAR signalling. J. Cell Sci. 2012, 125, 2369–2380. [Google Scholar] [CrossRef]
  9. Yoneda, M.; Hirokawa, Y.S.; Ohashi, A.; Uchida, K.; Kami, D.; Watanabe, M.; Yokoi, T.; Shiraishi, T.; Wakusawa, S. RhoB enhances migration and MMP1 expression of prostate cancer DU145. Exp. Mol. Pathol. 2010, 88, 90–95. [Google Scholar] [CrossRef]
  10. Ma, Y.; Gong, Y.; Cheng, Z.; Loganathan, S.; Kao, C.; Sarkaria, J.N.; Abel, T.W.; Wang, J. Critical functions of RhoB in support of glioblastoma tumorigenesis. Neuro-Oncology 2014, 17, 516–525. [Google Scholar] [CrossRef]
  11. Luis-Ravelo, D.; Antón, I.; Zandueta, C.; Valencia, K.; Pajares, M.-J.; Agorreta, J.; Montuenga, L.; Vicent, S.; Wistuba, I.I.; Rivas, J.D.L.; et al. RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner. Mol. Oncol. 2014, 8, 196–206. [Google Scholar] [CrossRef]
  12. Huang, M.; Prendergast, G.C. RhoB in cancer suppression. Histol. Histopathol. 2006, 21, 213–218. [Google Scholar] [CrossRef] [PubMed]
  13. Ridley, A.J. RhoA, RhoB and RhoC have different roles in cancer cell migration. J. Microsc. 2013, 251, 242–249. [Google Scholar] [CrossRef] [PubMed]
  14. Ju, J.A.; Gilkes, D.M. RhoB: Team Oncogene or Team Tumor Suppressor? Genes 2018, 9, 67. [Google Scholar] [CrossRef] [PubMed]
  15. Vega, F.M.; Ridley, A.J. The RhoB small GTPase in physiology and disease. Small GTPases 2018, 9, 384–393. [Google Scholar] [CrossRef]
  16. Fernandez-Borja, M.; Janssen, L.; Verwoerd, D.; Hordijk, P.; Neefjes, J. RhoB regulates endosome transport by promoting actin assembly on endosomal membranes through Dia1. J. Cell Sci. 2005, 118, 2661–2670. [Google Scholar] [CrossRef]
  17. Reinhard, N.R.; van Helden, S.F.; Anthony, E.C.; Yin, T.; Wu, Y.I.; Goedhart, J.; Gadella, T.W.; Hordijk, P.L. Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. Sci. Rep. 2016, 6, 25502. [Google Scholar] [CrossRef]
  18. Sanchez, C.; Ramirez, A.; Hodgson, L. Unravelling molecular dynamics in living cells: Fluorescent protein biosensors for cell biology. J. Microsc. 2024, 298, 123–184. [Google Scholar] [CrossRef]
  19. Terai, K.; Imanishi, A.; Li, C.; Matsuda, M. Two Decades of Genetically Encoded Biosensors Based on Förster Resonance Energy Transfer. Cell Struct. Funct. 2019, 44, 153–169. [Google Scholar] [CrossRef]
  20. Gaits, F.; Hahn, K. Shedding light on cell signaling: Interpretation of FRET biosensors. Sci. STKE 2003, 2003, PE3. [Google Scholar] [CrossRef]
  21. Grecco, H.E.; Verveer, P.J. FRET in cell biology: Still shining in the age of super-resolution? Chemphyschem 2011, 12, 484–490. [Google Scholar] [CrossRef]
  22. Fritz, R.D.; Letzelter, M.; Reimann, A.; Martin, K.; Fusco, L.; Ritsma, L.; Ponsioen, B.; Fluri, E.; Schulte-Merker, S.; van Rheenen, J.; et al. A versatile toolkit to produce sensitive FRET biosensors to visualize signaling in time and space. Sci. Signal 2013, 6, rs12. [Google Scholar] [CrossRef] [PubMed]
  23. Pertz, O.; Hahn, K.M. Designing biosensors for Rho family proteins—Deciphering the dynamics of Rho family GTPase activation in living cells. J. Cell Sci. 2004, 117, 1313–1318. [Google Scholar] [CrossRef] [PubMed]
  24. Hanna, S.; Miskolci, V.; Cox, D.; Hodgson, L. A New Genetically Encoded Single-Chain Biosensor for Cdc42 Based on FRET, Useful for Live-Cell Imaging. PLoS ONE 2014, 9, e96469. [Google Scholar] [CrossRef] [PubMed]
  25. Moshfegh, Y.; Bravo-Cordero, J.J.; Miskolci, V.; Condeelis, J.; Hodgson, L. A Trio–Rac1–Pak1 signalling axis drives invadopodia disassembly. Nat. Cell Biol. 2014, 16, 571–583. [Google Scholar] [CrossRef]
  26. Pertz, O.; Hodgson, L.; Klemke, R.L.; Hahn, K.M. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 2006, 440, 1069–1072. [Google Scholar] [CrossRef]
  27. Donnelly, S.K.; Cabrera, R.; Mao, S.P.H.; Christin, J.R.; Wu, B.; Guo, W.; Bravo-Cordero, J.J.; Condeelis, J.S.; Segall, J.E.; Hodgson, L. Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation. J. Cell Biol. 2017, 216, 4331–4349. [Google Scholar] [CrossRef]
  28. Bravo-Cordero, J.J.; Hodgson, L.; Condeelis, J.S. Spatial regulation of tumor cell protrusions by RhoC. Cell Adh Migr. 2014, 8, 263–267. [Google Scholar] [CrossRef]
  29. Hulsemann, M.; Sanchez, C.; Verkhusha, P.V.; Des Marais, V.; Mao, S.P.H.; Donnelly, S.K.; Segall, J.E.; Hodgson, L. TC10 regulates breast cancer invasion and metastasis by controlling membrane type-1 matrix metalloproteinase at invadopodia. Commun. Biol. 2021, 4, 1091. [Google Scholar] [CrossRef]
  30. Miskolci, V.; Wu, B.; Moshfegh, Y.; Cox, D.; Hodgson, L. Optical Tools to Study the Isoform-Specific Roles of Small GTPases in Immune Cells. J. Immunol. 2016, 196, 3479–3493. [Google Scholar] [CrossRef]
  31. Ai, H.W.; Henderson, J.N.; Remington, S.J.; Campbell, R.E. Directed evolution of a monomeric, bright and photostable version of Clavularia cyan fluorescent protein: Structural characterization and applications in fluorescence imaging. Biochem. J. 2006, 400, 531–540. [Google Scholar] [CrossRef] [PubMed]
  32. Griesbeck, O.; Baird, G.S.; Campbell, R.E.; Zacharias, D.A.; Tsien, R.Y. Reducing the environmental sensitivity of yellow fluorescent protein. Mechanism and applications. J. Biol. Chem. 2001, 276, 29188–29194. [Google Scholar] [CrossRef] [PubMed]
  33. Nagai, T.; Yamada, S.; Tominaga, T.; Ichikawa, M.; Miyawaki, A. Expanded dynamic range of fluorescent indicators for Ca2+ by circularly permuted yellow fluorescent proteins. Proc. Natl. Acad. Sci. USA 2004, 101, 10554–10559. [Google Scholar] [CrossRef] [PubMed]
  34. Watson, R.T.; Shigematsu, S.; Chiang, S.H.; Mora, S.; Kanzaki, M.; Macara, I.G.; Saltiel, A.R.; Pessin, J.E. Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and GLUT4 translocation. J. Cell Biol. 2001, 154, 829–840. [Google Scholar] [CrossRef]
  35. Michaelson, D.; Silletti, J.; Murphy, G.; D’Eustachio, P.; Rush, M.; Philips, M.R. Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 2001, 152, 111–126. [Google Scholar] [CrossRef]
  36. Inoue, M.; Chiang, S.H.; Chang, L.; Chen, X.W.; Saltiel, A.R. Compartmentalization of the exocyst complex in lipid rafts controls Glut4 vesicle tethering. Mol. Biol. Cell 2006, 17, 2303–2311. [Google Scholar] [CrossRef]
  37. Gracias, N.G.; Shirkey-Son, N.J.; Hengst, U. Local translation of TC10 is required for membrane expansion during axon outgrowth. Nat. Commun. 2014, 5, 3506. [Google Scholar] [CrossRef]
  38. Kawase, K.; Nakamura, T.; Takaya, A.; Aoki, K.; Namikawa, K.; Kiyama, H.; Inagaki, S.; Takemoto, H.; Saltiel, A.R.; Matsuda, M. GTP hydrolysis by the Rho family GTPase TC10 promotes exocytic vesicle fusion. Dev. Cell 2006, 11, 411–421. [Google Scholar] [CrossRef]
  39. Zaoui, K.; Rajadurai, C.V.; Duhamel, S.; Park, M. Arf6 regulates RhoB subcellular localization to control cancer cell invasion. J. Cell Biol. 2019, 218, 3812–3826. [Google Scholar] [CrossRef]
  40. Zacharias, D.A.; Violin, J.D.; Newton, A.C.; Tsien, R.Y. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 2002, 296, 913–916. [Google Scholar] [CrossRef]
  41. Baird, G.S.; Zacharias, D.A.; Tsien, R.Y. Circular permutation and receptor insertion within green fluorescent proteins. Proc. Natl. Acad. Sci. USA 1999, 96, 11241–11246. [Google Scholar] [CrossRef] [PubMed]
  42. Whitlow, M.; Bell, B.A.; Feng, S.L.; Filpula, D.; Hardman, K.D.; Hubert, S.L.; Rollence, M.L.; Wood, J.F.; Schott, M.E.; Milenic, D.E. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng. 1993, 6, 989–995. [Google Scholar] [CrossRef] [PubMed]
  43. Wu, B.; Miskolci, V.; Sato, H.; Tutucci, E.; Kenworthy, C.A.; Donnelly, S.K.; Yoon, Y.J.; Cox, D.; Singer, R.H.; Hodgson, L. Synonymous modification results in high-fidelity gene expression of repetitive protein and nucleotide sequences. Genes Dev. 2015, 29, 876–886. [Google Scholar] [CrossRef] [PubMed]
  44. Cherfils, J.; Zeghouf, M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol. Rev. 2013, 93, 269–309. [Google Scholar] [CrossRef]
  45. Logan, M.R.; Jones, L.; Forsberg, D.; Bodman, A.; Baier, A.; Eitzen, G. Functional analysis of RhoGDI inhibitory activity on vacuole membrane fusion. Biochem. J. 2011, 434, 445–457. [Google Scholar] [CrossRef]
  46. Narumiya, S. The small GTPase Rho: Cellular functions and signal transduction. J. Biochem. 1996, 120, 215–228. [Google Scholar] [CrossRef]
  47. Adra, C.N.; Manor, D.; Ko, J.L.; Zhu, S.; Horiuchi, T.; Van Aelst, L.; Cerione, R.A.; Lim, B. RhoGDIgamma: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc. Natl. Acad. Sci. USA 1997, 94, 4279–4284. [Google Scholar] [CrossRef]
  48. Zalcman, G.; Closson, V.; Camonis, J.; Honore, N.; Rousseau-Merck, M.F.; Tavitian, A.; Olofsson, B. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J. Biol. Chem. 1996, 271, 30366–30374. [Google Scholar] [CrossRef]
  49. Knaus, U.G.; Bamberg, A.; Bokoch, G.M. Rac and Rap GTPase activation assays. Methods Mol. Biol. 2007, 412, 59–67. [Google Scholar] [CrossRef]
  50. Lei, M.; Lu, W.; Meng, W.; Parrini, M.C.; Eck, M.J.; Mayer, B.J.; Harrison, S.C. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 2000, 102, 387–397. [Google Scholar] [CrossRef]
  51. Ioannou, M.S.; Bell, E.S.; Girard, M.; Chaineau, M.; Hamlin, J.N.; Daubaras, M.; Monast, A.; Park, M.; Hodgson, L.; McPherson, P.S. DENND2B activates Rab13 at the leading edge of migrating cells and promotes metastatic behavior. J. Cell Biol. 2015, 208, 629–648. [Google Scholar] [CrossRef] [PubMed]
  52. Phuyal, S.; Farhan, H. Multifaceted Rho GTPase Signaling at the Endomembranes. Front. Cell Dev. Biol. 2019, 7, 127. [Google Scholar] [CrossRef] [PubMed]
  53. Watson, R.T.; Furukawa, M.; Chiang, S.H.; Boeglin, D.; Kanzaki, M.; Saltiel, A.R.; Pessin, J.E. The exocytotic trafficking of TC10 occurs through both classical and nonclassical secretory transport pathways in 3T3L1 adipocytes. Mol. Cell Biol. 2003, 23, 961–974. [Google Scholar] [CrossRef] [PubMed]
  54. Tatsis, N.; Lannigan, D.A.; Macara, I.G. The function of the p190 Rho GTPase-activating protein is controlled by its N-terminal GTP binding domain. J. Biol. Chem. 1998, 273, 34631–34638. [Google Scholar] [CrossRef]
  55. Bajar, B.T.; Wang, E.S.; Lam, A.J.; Kim, B.B.; Jacobs, C.L.; Howe, E.S.; Davidson, M.W.; Lin, M.Z.; Chu, J. Improving brightness and photostability of green and red fluorescent proteins for live cell imaging and FRET reporting. Sci. Rep. 2016, 6, 20889. [Google Scholar] [CrossRef]
  56. Machacek, M.; Hodgson, L.; Welch, C.; Elliott, H.; Pertz, O.; Nalbant, P.; Abell, A.; Johnson, G.L.; Hahn, K.M.; Danuser, G. Coordination of Rho GTPase activities during cell protrusion. Nature 2009, 461, 99–103. [Google Scholar] [CrossRef]
  57. Marcos-Ramiro, B.; Garcia-Weber, D.; Barroso, S.; Feito, J.; Ortega, M.C.; Cernuda-Morollon, E.; Reglero-Real, N.; Fernandez-Martin, L.; Duran, M.C.; Alonso, M.A.; et al. RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border. J. Cell Biol. 2016, 213, 385–402. [Google Scholar] [CrossRef]
  58. Huang, M.; Satchell, L.; Duhadaway, J.B.; Prendergast, G.C.; Laury-Kleintop, L.D. RhoB links PDGF signaling to cell migration by coordinating activation and localization of Cdc42 and Rac. J. Cell Biochem. 2011, 112, 1572–1584. [Google Scholar] [CrossRef]
  59. Garcia-Weber, D.; Millan, J. Parallels between single cell migration and barrier formation: The case of RhoB and Rac1 trafficking. Small GTPases 2018, 9, 332–338. [Google Scholar] [CrossRef][Green Version]
  60. Huang, M.; Duhadaway, J.B.; Prendergast, G.C.; Laury-Kleintop, L.D. RhoB regulates PDGFR-beta trafficking and signaling in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2597–2605. [Google Scholar] [CrossRef]
  61. Dupraz, S.; Grassi, D.; Bernis, M.E.; Sosa, L.; Bisbal, M.; Gastaldi, L.; Jausoro, I.; Caceres, A.; Pfenninger, K.H.; Quiroga, S. The TC10-Exo70 complex is essential for membrane expansion and axonal specification in developing neurons. J. Neurosci. 2009, 29, 13292–13301. [Google Scholar] [CrossRef] [PubMed]
  62. Neri, A.; Nicolson, G.L. Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro. Int. J. Cancer 1981, 28, 731–738. [Google Scholar] [CrossRef] [PubMed]
  63. Segall, J.E.; Tyerech, S.; Boselli, L.; Masseling, S.; Helft, J.; Chan, A.; Jones, J.; Condeelis, J. EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism. Clin. Exp. Metast. 1996, 14, 61–72. [Google Scholar] [CrossRef] [PubMed]
  64. Gossen, M.; Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 1992, 89, 5547–5551. [Google Scholar] [CrossRef]
  65. Loew, R.; Heinz, N.; Hampf, M.; Bujard, H.; Gossen, M. Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol. 2010, 10, 81. [Google Scholar] [CrossRef]
  66. Brunet, J.P.; Cotte-Laffitte, J.; Linxe, C.; Quero, A.M.; Geniteau-Legendre, M.; Servin, A. Rotavirus infection induces an increase in intracellular calcium concentration in human intestinal epithelial cells: Role in microvillar actin alteration. J. Virol. 2000, 74, 2323–2332. [Google Scholar] [CrossRef]
  67. Brunet, J.P.; Jourdan, N.; Cotte-Laffitte, J.; Linxe, C.; Geniteau-Legendre, M.; Servin, A.; Quero, A.M. Rotavirus infection induces cytoskeleton disorganization in human intestinal epithelial cells: Implication of an increase in intracellular calcium concentration. J. Virol. 2000, 74, 10801–10806. [Google Scholar] [CrossRef]
  68. Bhalla, R.M.; Hulsemann, M.; Verkhusha, P.V.; Walker, M.G.; Shcherbakova, D.M.; Hodgson, L. Multiplex Imaging of Rho GTPase Activities in Living Cells. Methods Mol. Biol. 2021, 2350, 43–68. [Google Scholar] [CrossRef]
  69. Chen, M.; Bresnick, A.R.; O’Connor, K.L. Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells. Oncogene 2013, 32, 3754–3764. [Google Scholar] [CrossRef]
  70. von Stetten, D.; Noirclerc-Savoye, M.; Goedhart, J.; Gadella, T.W., Jr.; Royant, A. Structure of a fluorescent protein from Aequorea victoria bearing the obligate-monomer mutation A206K. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2012, 68, 878–882. [Google Scholar] [CrossRef]
  71. Chang, J.; Saraswathibhatla, A.; Song, Z.; Varma, S.; Sanchez, C.; Alyafei, N.H.K.; Indana, D.; Slyman, R.; Srivastava, S.; Liu, K.; et al. Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer. Nat. Mater. 2023, 23, 711–722. [Google Scholar] [CrossRef]
  72. Ehrhardt, C.; Schmolke, M.; Matzke, A.; Knoblauch, A.; Will, C.; Wixler, V.; Ludwig, S. Polyethylenimine, a cost-effective transfection reagent. Signal Transduct. 2006, 6, 179–184. [Google Scholar] [CrossRef]
  73. Spiering, D.; Hodgson, L. Multiplex Imaging of Rho Family GTPase Activities in Living Cells. Methods Mol. Biol. 2012, 827, 215–234. [Google Scholar] [CrossRef]
  74. Spiering, D.; Bravo-Cordero, J.J.; Moshfegh, Y.; Miskolci, V.; Hodgson, L. Quantitative Ratiometric Imaging of FRET-Biosensors in Living Cells. Methods Cell Biol. 2013, 114, 593–609. [Google Scholar] [CrossRef]
Figure 1. Design and validation of a CFP–YFP single-chain genetically encoded RhoB biosensor. (A) Linear schematic of the RhoB biosensor (top), composed from N- to C-terminus of the PKN Rho-binding domain (RBD), mECFP, a flexible linker, circularly permuted mCitrine, and full-length RhoB. The FRET mechanism (bottom) relies on the intramolecular interaction between GTP-bound RhoB and the PKN RBD, which increases FRET upon GDP–GTP exchange. (B) Normalized donor emission spectra of constitutively active (G14V) and dominant-negative (T19N) RhoB biosensors in LinXe cells (excitation 433 nm; normalized at 474 nm). (C) Normalized FRET/CFP ratios of wild-type (WT) and mutant RhoB biosensors, or WT biosensor co-expressed with RhoGDIs or dominant-negative Rho GTPases, in LinXe cells. (DH) FRET/CFP ratios of the WT RhoB biosensor expressed alone or with RabGDI and indicated GEF families in LinXe cells, including RabGDI titration (D). (I) FRET/CFP ratios of the WT RhoB biosensor co-expressed with GAPs. (J) Representative ratiometric images and quantification of constitutively active (F30L) and dominant-negative (T19N) RhoB biosensors in MTLn3 cells. Scale bar, 20 µm. (K) PKN-RBD pull-down assay validating biosensor specificity using monomeric GreenLantern-tagged RhoB mutants and control biosensors in LinXe cells. Data are shown as mean ± SEM from 3–7 independent experiments. Statistical significance was assessed using unpaired t-tests (* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns, not significant).
Figure 1. Design and validation of a CFP–YFP single-chain genetically encoded RhoB biosensor. (A) Linear schematic of the RhoB biosensor (top), composed from N- to C-terminus of the PKN Rho-binding domain (RBD), mECFP, a flexible linker, circularly permuted mCitrine, and full-length RhoB. The FRET mechanism (bottom) relies on the intramolecular interaction between GTP-bound RhoB and the PKN RBD, which increases FRET upon GDP–GTP exchange. (B) Normalized donor emission spectra of constitutively active (G14V) and dominant-negative (T19N) RhoB biosensors in LinXe cells (excitation 433 nm; normalized at 474 nm). (C) Normalized FRET/CFP ratios of wild-type (WT) and mutant RhoB biosensors, or WT biosensor co-expressed with RhoGDIs or dominant-negative Rho GTPases, in LinXe cells. (DH) FRET/CFP ratios of the WT RhoB biosensor expressed alone or with RabGDI and indicated GEF families in LinXe cells, including RabGDI titration (D). (I) FRET/CFP ratios of the WT RhoB biosensor co-expressed with GAPs. (J) Representative ratiometric images and quantification of constitutively active (F30L) and dominant-negative (T19N) RhoB biosensors in MTLn3 cells. Scale bar, 20 µm. (K) PKN-RBD pull-down assay validating biosensor specificity using monomeric GreenLantern-tagged RhoB mutants and control biosensors in LinXe cells. Data are shown as mean ± SEM from 3–7 independent experiments. Statistical significance was assessed using unpaired t-tests (* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns, not significant).
Cells 15 00347 g001
Figure 2. Spatial characterization of RhoB and TC10 biosensor activity in stable MEFs. (A) Representative high-resolution microscopy images of whole-cell MEFs showing DIC, ratiometric images of stably expressed RhoB and TC10 biosensors, and transient pTriEx-mRuby3 expression in control cells. Scale bar, 20 µm. (B) Representative ratiometric time-lapse images of MEFs constitutively expressing RhoB and TC10 biosensors at the leading edge under control conditions (box from panel (A)). Scale bars: top, 10 µm; bottom, 5 µm. (C) Representative ratiometric time-lapse images of RhoB and TC10 biosensor activity during protrusion–retraction cycles in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs. (D) Corresponding line-scan analyses along the indicated region show RhoB (upper plots) and TC10 (lower plots) activities in control (blue) and p190DN (red) conditions. Scale bar, 5 µm.
Figure 2. Spatial characterization of RhoB and TC10 biosensor activity in stable MEFs. (A) Representative high-resolution microscopy images of whole-cell MEFs showing DIC, ratiometric images of stably expressed RhoB and TC10 biosensors, and transient pTriEx-mRuby3 expression in control cells. Scale bar, 20 µm. (B) Representative ratiometric time-lapse images of MEFs constitutively expressing RhoB and TC10 biosensors at the leading edge under control conditions (box from panel (A)). Scale bars: top, 10 µm; bottom, 5 µm. (C) Representative ratiometric time-lapse images of RhoB and TC10 biosensor activity during protrusion–retraction cycles in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs. (D) Corresponding line-scan analyses along the indicated region show RhoB (upper plots) and TC10 (lower plots) activities in control (blue) and p190DN (red) conditions. Scale bar, 5 µm.
Cells 15 00347 g002
Figure 3. Morphodynamic analysis of RhoB activation dynamics during random protrusions in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. Morphodynamic analysis was performed in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. The same cells were used for quantification of both RhoB (Figure 3) and TC10 (Figure 4) activities. (A) Schematic of the window-strip strategy used for protrusion–RhoB cross-correlation analysis. Ten window strips (6 × 3 pixels) were positioned from the cell edge toward distal regions in 3-pixel increments. (B) Cross-correlation between RhoB activity and protrusion velocity in control and p190DN MEFs. Curves were computed from 535 windows (12 cells, 4 experiments) for control and 639 windows (11 cells, 3 experiments) for p190DN. Data are shown as mean ± 95% CI (shaded red and blue regions). Black and green arrows indicate positions analyzed in (C,D). (C,D) RhoB activity–protrusion velocity cross-correlation at increasing distances from the cell edge at the black (C) and green (D) arrow positions shown in (B), for control (blue) and p190DN (red) MEFs. Data are shown as mean ± 95% CI. Statistical significance was assessed using an unpaired t-test (* p < 0.05).
Figure 3. Morphodynamic analysis of RhoB activation dynamics during random protrusions in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. Morphodynamic analysis was performed in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. The same cells were used for quantification of both RhoB (Figure 3) and TC10 (Figure 4) activities. (A) Schematic of the window-strip strategy used for protrusion–RhoB cross-correlation analysis. Ten window strips (6 × 3 pixels) were positioned from the cell edge toward distal regions in 3-pixel increments. (B) Cross-correlation between RhoB activity and protrusion velocity in control and p190DN MEFs. Curves were computed from 535 windows (12 cells, 4 experiments) for control and 639 windows (11 cells, 3 experiments) for p190DN. Data are shown as mean ± 95% CI (shaded red and blue regions). Black and green arrows indicate positions analyzed in (C,D). (C,D) RhoB activity–protrusion velocity cross-correlation at increasing distances from the cell edge at the black (C) and green (D) arrow positions shown in (B), for control (blue) and p190DN (red) MEFs. Data are shown as mean ± 95% CI. Statistical significance was assessed using an unpaired t-test (* p < 0.05).
Cells 15 00347 g003
Figure 4. Morphodynamic analysis of TC10 activation dynamics during random protrusions in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. Morphodynamic analysis was performed in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. The same cells were used for quantification of both RhoB (Figure 3) and TC10 (Figure 4) activities. (A) Cross-correlation between TC10 activity and protrusion velocity in control and p190DN MEFs. Curves were computed from 535 windows (12 cells, 4 experiments) for control and 639 windows (11 cells, 3 experiments) for p190DN. Data are shown as mean ± 95% CI (shaded red and blue regions). (B) TC10 activity–protrusion velocity cross-correlation at increasing distances from the cell edge (black arrow in (A)) for control (blue) and p190DN (red) MEFs. Data are shown as mean ± 95% CI. Statistical significance was assessed using an unpaired t-test (* p < 0.05).
Figure 4. Morphodynamic analysis of TC10 activation dynamics during random protrusions in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. Morphodynamic analysis was performed in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. The same cells were used for quantification of both RhoB (Figure 3) and TC10 (Figure 4) activities. (A) Cross-correlation between TC10 activity and protrusion velocity in control and p190DN MEFs. Curves were computed from 535 windows (12 cells, 4 experiments) for control and 639 windows (11 cells, 3 experiments) for p190DN. Data are shown as mean ± 95% CI (shaded red and blue regions). (B) TC10 activity–protrusion velocity cross-correlation at increasing distances from the cell edge (black arrow in (A)) for control (blue) and p190DN (red) MEFs. Data are shown as mean ± 95% CI. Statistical significance was assessed using an unpaired t-test (* p < 0.05).
Cells 15 00347 g004
Figure 5. Morphodynamic analysis of RhoB and TC10 activation dynamics during random protrusions in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. (A) Correlation of RhoB activity and TC10 activity monitored in the same cell in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing both RhoB and TC10 biosensors. Correlation curves were computed from n = 535 individual windows across 12 cells from 4 independent experiments for the control condition, and n = 639 individual windows across 11 cells from 3 independent experiments for the p190DN condition. Data are presented as mean ± 95% CI (shaded red and blue regions). (B) RhoB activity and TC10 activity cross-correlation at different distances from the cell edge, measured at the black arrow position indicated in panel (A), in control (blue trace) and p190RhoGAP dominant-negative (p190DN)-transfected (red trace) MEFs constitutively expressing both RhoB and TC10 biosensors. Correlation curves were computed from n = 535 individual windows across 12 cells from 4 independent experiments for the control condition, and n = 639 individual windows across 11 cells from 3 independent experiments for the p190DN condition. Data are presented as mean ± 95% CI. Statistical significance was assessed using an unpaired t-test. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Figure 5. Morphodynamic analysis of RhoB and TC10 activation dynamics during random protrusions in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing RhoB and TC10 biosensors. (A) Correlation of RhoB activity and TC10 activity monitored in the same cell in control and p190RhoGAP dominant-negative (p190DN)-transfected MEFs constitutively expressing both RhoB and TC10 biosensors. Correlation curves were computed from n = 535 individual windows across 12 cells from 4 independent experiments for the control condition, and n = 639 individual windows across 11 cells from 3 independent experiments for the p190DN condition. Data are presented as mean ± 95% CI (shaded red and blue regions). (B) RhoB activity and TC10 activity cross-correlation at different distances from the cell edge, measured at the black arrow position indicated in panel (A), in control (blue trace) and p190RhoGAP dominant-negative (p190DN)-transfected (red trace) MEFs constitutively expressing both RhoB and TC10 biosensors. Correlation curves were computed from n = 535 individual windows across 12 cells from 4 independent experiments for the control condition, and n = 639 individual windows across 11 cells from 3 independent experiments for the p190DN condition. Data are presented as mean ± 95% CI. Statistical significance was assessed using an unpaired t-test. * p < 0.05; ** p < 0.01; **** p < 0.0001.
Cells 15 00347 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pagano, S.; Hodgson, L. A New Single-Chain, Genetically Encoded Biosensor for RhoB GTPase Based on FRET, Useful for Live-Cell Imaging. Cells 2026, 15, 347. https://doi.org/10.3390/cells15040347

AMA Style

Pagano S, Hodgson L. A New Single-Chain, Genetically Encoded Biosensor for RhoB GTPase Based on FRET, Useful for Live-Cell Imaging. Cells. 2026; 15(4):347. https://doi.org/10.3390/cells15040347

Chicago/Turabian Style

Pagano, Sandra, and Louis Hodgson. 2026. "A New Single-Chain, Genetically Encoded Biosensor for RhoB GTPase Based on FRET, Useful for Live-Cell Imaging" Cells 15, no. 4: 347. https://doi.org/10.3390/cells15040347

APA Style

Pagano, S., & Hodgson, L. (2026). A New Single-Chain, Genetically Encoded Biosensor for RhoB GTPase Based on FRET, Useful for Live-Cell Imaging. Cells, 15(4), 347. https://doi.org/10.3390/cells15040347

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop